TVM Capital Healthcare Announces US$ 17 Million Investment into neurocare
Summary
neurocare is revolutionizing mental health care by providing innovative methods and tools based on neurostimulation and other technologies to help clinicians deliver personalized treatments with sustainable clinical outcomes for patients. The investment will enable the company to execute on its growth plans, including expansion into the MENA region.DUBAI, UAE, April 24, 2024 /PRNewswire/ -- TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and Singapore, today announced a US$ 17 million investment into Munich-headquartered neurocare group AG (neurocare), a leading innovator in personalized mental health care, providing solutions to empower clinicians to deliver best care to their patients. TVM Capital Healthcares investment will enable neurocare to execute on its international growth plans, including expansion in the US and market entry into the Kingdom of Saudi Arabia, as well as support the development of new hardware and software innovations. The treatment of mental health conditions remains nevertheless significantly lacking in most countries, leaving a considerable portion of the population without the necessary support, and presenting a unique growth opportunity for companies like neurocare offering innovative non-invasive treatments with superior clinical outcomes.Tristan de Boysson, Managing Partner, TVM Capital Healthcare, stated: "This investment is part of our strategy of investing in highly innovative, best-in-class healthcare solutions that improve access to quality care across the globe. neurocares digital therapy platform (DTP) is the first of its kind in the area of mental health and is empowering doctors to offer their patients the best care for a variety of psychological or neurological conditions.